VanEck Pharmaceutical ETF reported 25 holdings worth US$879M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 26, 2026
VanEck Pharmaceutical ETF reported 25 holdings worth US$879M as of Jun 30, 2026. Largest: Eli Lilly And Company, Novartis Ag and Merck & Company, Inc. Filed Aug 26, 2026 (Form N-PORT).
- Holdings
- 25
- Value as reported
- US$879M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Eli Lilly And Company | 148K | US$178M | 20.2% |
| Novartis Ag | 598K | US$93.4M | 10.6% |
| Merck & Company, Inc. | 674K | US$86.6M | 9.8% |
| Novo Nordisk A/s Class B | 998K | US$47.2M | 5.4% |
| Abbvie Inc. | 160K | US$40.2M | 4.6% |
| Pfizer, Inc. | 1.65M | US$39.6M | 4.5% |
| Bristol-myers Squibb Company | 682K | US$39.3M | 4.5% |
| Gsk Plc | 1.47M | US$38.9M | 4.4% |
| Johnson & Johnson | 151K | US$38.3M | 4.4% |
| Astrazeneca Plc | 201K | US$38.1M | 4.3% |
| Mckesson Corporation | 47,981 | US$36.3M | 4.1% |
| Sanofi Sa | 414K | US$35.2M | 4.0% |
| Cencora, Inc. | 104K | US$29.5M | 3.4% |
| Haleon Plc | 5.89M | US$27.2M | 3.1% |
| Teva Pharmaceutical Industries Limited | 794K | US$26.9M | 3.1% |
| Takeda Pharmaceutical Co. Ltd. | 791K | US$25.3M | 2.9% |
| Zoetis Inc. | 257K | US$18.5M | 2.1% |
| Viatris Inc. | 606K | US$9.63M | 1.1% |
| Jazz Pharmaceuticals Plc | 39,436 | US$9.5M | 1.1% |
| Axsome Therapeutics, Inc. | 27,589 | US$6.75M | 0.77% |
| Corcept Therapeutics Incorporated | 50,964 | US$4.43M | 0.50% |
| Elanco Animal Health Incorporated | 126K | US$3.11M | 0.35% |
| Organon & Co. | 149K | US$2.01M | 0.23% |
| Bausch Health Companies Inc. | 175K | US$861K | 0.10% |
| Perrigo Company Plc | 50,862 | US$528K | 0.06% |